Regular paper
Altered regulation of surfactant phospholipid and protein A during acute pulmonary inflammation

https://doi.org/10.1016/0005-2760(95)00167-0Get rights and content

Abstract

Biochemical changes in the pulmonary surfactant system caused by exposure to toxicants are often accompanied by an influx of inflammatory cells into the lungs. We have investigated the possibility that the inflammatory and surfactant biochemical effects might be connected. Co-treatment with dexamethasone, a synthetic anti-inflammatory glucocorticoid, mitigated the increases in free cells and total intracellular surfactant phospholipid normally seen in animals given silica alone, suggesting a relationship between the free cell population of the alveoli and the surfactant system during alveolitis. Furthermore, we have investigated whether induction of the surfactant system is a universal response to alveolar inflammation. Inflammation was induced in the lungs by intratracheal injections of titanium dioxide, silica, bleomycin or lipopolysaccharide (LPS) suspended in isotonic saline. Inflammatory cell and surfactant responses were measured at 3 days and 14 days following injection. There was a distinct alveolar inflammatory cell profile following administration of each agent, at each time point, indicating a dynamic inflammatory cell population during the course of the study. Furthermore, surfactant phospholipid and protein A (SP-A) pools exhibited unique responses to the inflammatory agents. Only silica-treated lungs maintained elevated levels of surfactant phospholipids and SP-A throughout the course of the experiment. We conclude that both the surfactant components and the inflammatory cell population of the alveoli undergo dynamic changes following treatment with these inflammatory agents and that activation of the surfactant system is not a universal response to alveolar inflammation, since surfactant components were not always elevated during times of increased alveolar cellularity. The unique inflammatory cell infiltrate elicited by silica is of particular interest in that surfactant components were elevated throughout the course of the experiment in this group. Indeed, we have shown that the size of the intracellular pool of surfactant is directly proportional to the number of polymorphonuclear leukocytes but not alveolar macrophages or lymphocytes in the alveoli following silica treatment. Finally, our data suggest that the phospholipid and SP-A components of surfactant respond differentially to the pulmonary toxicants in this study.

References (48)

  • S. Schurch et al.

    Respir. Physiol.

    (1990)
  • G.S. Davis et al.

    Chest

    (1981)
  • J. Folch et al.

    J. Biol. Chem.

    (1957)
  • S. Hirano et al.

    Toxicology

    (1989)
  • R.D. DeShazo

    J. Allergy Clin. Immunol.

    (1982)
  • L.A. Dethloff et al.

    Toxicol. Appl. Pharmacol.

    (1989)
  • Y. Kusaka et al.

    Environ. Res.

    (1990)
  • Y. Oda et al.

    Life Sci.

    (1991)
  • A.J. Tenner et al.

    J. Biol. Chem.

    (1989)
  • H. Weber et al.

    FEBS Lett.

    (1990)
  • J.A. Whitsett et al.

    J. Biol. Chem.

    (1987)
  • L.M.G. Van Golde et al.

    Physiol. Rev.

    (1988)
  • T.E. Weaver et al.

    Biochem. J.

    (1991)
  • C. Jarstrand
  • W.E. Wallace et al.

    J. Toxicol. Environ. Health

    (1985)
  • L.A. Dethloff et al.

    Biochem. J.

    (1986)
  • L.A. Dethloff et al.

    Biochem. J.

    (1986)
  • B.E. Miller et al.

    Am. J. Respir. Cell Mol. Biol.

    (1990)
  • B.E. Miller et al.

    Lab. Invest.

    (1988)
  • B.E. Miller et al.

    Environ. Health Perspect.

    (1990)
  • G.S. Davis

    Lung

    (1986)
  • L.A. Dethloff et al.

    Am. Rev. Respir. Dis.

    (1987)
  • K.E. Driscoll et al.

    Am. J. Respir. Cell Mol. Biol.

    (1990)
  • K.M. Reiser et al.

    Am. J. Pathol.

    (1982)
  • Cited by (31)

    • Silica binding and toxicity in alveolar macrophages

      2008, Free Radical Biology and Medicine
      Citation Excerpt :

      One study found three- to sevenfold increases in PL and SP, respectively, occurring in a rat model with acid-washed silica, but not with unwashed silica [15]. Another study found sustained elevations (in weeks) in PL and SP-A in response to silica [16]. Several other studies found silica-induced increases in PL and SP [17,18], including specific increases in SP-A [19,20], SP-D [19,21], vitamin E [22], and phosphatidyl inositol [23].

    • Tacrolimus (FK506) has protective actions against murine bleomycin-induced acute lung injuries

      2005, European Journal of Pharmacology
      Citation Excerpt :

      In this study, we showed that tacrolimus significantly improved survival rate in a bleomycin-evoked acute lung injury model, while treatment with dexamethasone failed. Some reports have shown that dexamethasone treatment significantly inhibits lung injury induced by several kinds of toxins including bleomycin (Grunze et al., 1988; Viviano et al., 1995), while other did not inhibit lung injury (Khalil et al., 1993). One possible explanation for this discrepancy may be that the dose of dexamethasone used in this study was not high enough to observe such a beneficial effect.

    • Increased Surfactant Protein-A Levels in Patients with Newly Diagnosed Idiopathic Pulmonary Fibrosis

      2004, Chest
      Citation Excerpt :

      However, it is not clear how these proteins enter the blood and whether they have any function there. It should also be noted that SP-A levels in the lung are increased fairly rapidly after the administration of bleomycin in a rodent model of bleomycin-induced pulmonary fibrosis.39 The basis for the different SP-A results among studies is not clear.

    • Neonatal Pulmonary Host Defense Mechanisms

      2003, Fetal and Neonatal Physiology: Third Edition
    View all citing articles on Scopus
    View full text